The global Intravenous Immunoglobulin (IVIg) market size was valued at US$ 11890 million in 2024 and is forecast to a readjusted size of USD 17520 million by 2031 with a CAGR of 5.8% during review period.
Intravenous Immunoglobulin, also called gamma globulin or antibodies, is a highly purified blood product preparation that is derived from large pools of plasma donors. Plasma from approximately 1,000 to 10,000 persons is present in each unit or 鈥渓ot鈥� of Intravenous Immunoglobulin.
Global Intravenous Immunoglobulin (IVIg) main players are Baxter, Grifols, CSL, Octapharma, etc. Global top four manufacturers hold a share above 65%. North America is the largest market, with a share about 45%.
This report is a detailed and comprehensive analysis for global Intravenous Immunoglobulin (IVIg) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Intravenous Immunoglobulin (IVIg) market size and forecasts, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Intravenous Immunoglobulin (IVIg) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Intravenous Immunoglobulin (IVIg) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Bottle), and average selling prices (USD/Bottle), 2020-2031
Global Intravenous Immunoglobulin (IVIg) market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottle), and ASP (USD/Bottle), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Intravenous Immunoglobulin (IVIg)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Intravenous Immunoglobulin (IVIg) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Intravenous Immunoglobulin (IVIg) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
IVIg Liquid
IVIg Powder
麻豆原创 segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Major players covered
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Intravenous Immunoglobulin (IVIg) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Intravenous Immunoglobulin (IVIg), with price, sales quantity, revenue, and global market share of Intravenous Immunoglobulin (IVIg) from 2020 to 2025.
Chapter 3, the Intravenous Immunoglobulin (IVIg) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Intravenous Immunoglobulin (IVIg) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Intravenous Immunoglobulin (IVIg) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Intravenous Immunoglobulin (IVIg).
Chapter 14 and 15, to describe Intravenous Immunoglobulin (IVIg) sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Intravenous Immunoglobulin (IVIg) Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 IVIg Liquid
1.3.3 IVIg Powder
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Immunodeficiency
1.4.3 Autoimmune Disease
1.4.4 Acute Infection
1.5 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size & Forecast
1.5.1 Global Intravenous Immunoglobulin (IVIg) Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Intravenous Immunoglobulin (IVIg) Sales Quantity (2020-2031)
1.5.3 Global Intravenous Immunoglobulin (IVIg) Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Baxter
2.1.1 Baxter Details
2.1.2 Baxter Major Business
2.1.3 Baxter Intravenous Immunoglobulin (IVIg) Product and Services
2.1.4 Baxter Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Baxter Recent Developments/Updates
2.2 Grifols
2.2.1 Grifols Details
2.2.2 Grifols Major Business
2.2.3 Grifols Intravenous Immunoglobulin (IVIg) Product and Services
2.2.4 Grifols Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Grifols Recent Developments/Updates
2.3 CSL
2.3.1 CSL Details
2.3.2 CSL Major Business
2.3.3 CSL Intravenous Immunoglobulin (IVIg) Product and Services
2.3.4 CSL Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 CSL Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Intravenous Immunoglobulin (IVIg) Product and Services
2.4.4 Octapharma Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 Octapharma Recent Developments/Updates
2.5 Biotest
2.5.1 Biotest Details
2.5.2 Biotest Major Business
2.5.3 Biotest Intravenous Immunoglobulin (IVIg) Product and Services
2.5.4 Biotest Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Biotest Recent Developments/Updates
2.6 Kedrion
2.6.1 Kedrion Details
2.6.2 Kedrion Major Business
2.6.3 Kedrion Intravenous Immunoglobulin (IVIg) Product and Services
2.6.4 Kedrion Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Kedrion Recent Developments/Updates
2.7 Hualan Bio
2.7.1 Hualan Bio Details
2.7.2 Hualan Bio Major Business
2.7.3 Hualan Bio Intravenous Immunoglobulin (IVIg) Product and Services
2.7.4 Hualan Bio Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Hualan Bio Recent Developments/Updates
2.8 CNBG
2.8.1 CNBG Details
2.8.2 CNBG Major Business
2.8.3 CNBG Intravenous Immunoglobulin (IVIg) Product and Services
2.8.4 CNBG Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 CNBG Recent Developments/Updates
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Product and Services
2.9.4 Shanghai RAAS Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Shanghai RAAS Recent Developments/Updates
2.10 CBPO
2.10.1 CBPO Details
2.10.2 CBPO Major Business
2.10.3 CBPO Intravenous Immunoglobulin (IVIg) Product and Services
2.10.4 CBPO Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 CBPO Recent Developments/Updates
2.11 LFB Group
2.11.1 LFB Group Details
2.11.2 LFB Group Major Business
2.11.3 LFB Group Intravenous Immunoglobulin (IVIg) Product and Services
2.11.4 LFB Group Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 LFB Group Recent Developments/Updates
2.12 BPL
2.12.1 BPL Details
2.12.2 BPL Major Business
2.12.3 BPL Intravenous Immunoglobulin (IVIg) Product and Services
2.12.4 BPL Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 BPL Recent Developments/Updates
2.13 Sichuan Yuanda Shuyang
2.13.1 Sichuan Yuanda Shuyang Details
2.13.2 Sichuan Yuanda Shuyang Major Business
2.13.3 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Product and Services
2.13.4 Sichuan Yuanda Shuyang Intravenous Immunoglobulin (IVIg) Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 Sichuan Yuanda Shuyang Recent Developments/Updates
3 Competitive Environment: Intravenous Immunoglobulin (IVIg) by Manufacturer
3.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Manufacturer (2020-2025)
3.2 Global Intravenous Immunoglobulin (IVIg) Revenue by Manufacturer (2020-2025)
3.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Intravenous Immunoglobulin (IVIg) by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Intravenous Immunoglobulin (IVIg) Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Intravenous Immunoglobulin (IVIg) Manufacturer 麻豆原创 Share in 2024
3.5 Intravenous Immunoglobulin (IVIg) 麻豆原创: Overall Company Footprint Analysis
3.5.1 Intravenous Immunoglobulin (IVIg) 麻豆原创: Region Footprint
3.5.2 Intravenous Immunoglobulin (IVIg) 麻豆原创: Company Product Type Footprint
3.5.3 Intravenous Immunoglobulin (IVIg) 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Region
4.1.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2020-2031)
4.1.2 Global Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2020-2031)
4.1.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Region (2020-2031)
4.2 North America Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
4.3 Europe Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
4.4 Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
4.5 South America Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
4.6 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
5.2 Global Intravenous Immunoglobulin (IVIg) Consumption Value by Type (2020-2031)
5.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
6.2 Global Intravenous Immunoglobulin (IVIg) Consumption Value by Application (2020-2031)
6.3 Global Intravenous Immunoglobulin (IVIg) Average Price by Application (2020-2031)
7 North America
7.1 North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
7.2 North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
7.3 North America Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Country
7.3.1 North America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
7.3.2 North America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
8.2 Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
8.3 Europe Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Country
8.3.1 Europe Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
8.3.2 Europe Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Region
9.3.1 Asia-Pacific Intravenous Immunoglobulin (IVIg) Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
10.2 South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
10.3 South America Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Country
10.3.1 South America Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
10.3.2 South America Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Intravenous Immunoglobulin (IVIg) 麻豆原创 Size by Country
11.3.1 Middle East & Africa Intravenous Immunoglobulin (IVIg) Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Intravenous Immunoglobulin (IVIg) 麻豆原创 Drivers
12.2 Intravenous Immunoglobulin (IVIg) 麻豆原创 Restraints
12.3 Intravenous Immunoglobulin (IVIg) Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Intravenous Immunoglobulin (IVIg) and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravenous Immunoglobulin (IVIg)
13.3 Intravenous Immunoglobulin (IVIg) Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravenous Immunoglobulin (IVIg) Typical Distributors
14.3 Intravenous Immunoglobulin (IVIg) Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
听
听
*If Applicable.
